SPRY logo

ARS Pharmaceuticals, Inc.

SPRY
Healthcare|Biotechnology|US
$2.79
+0.14 (+5.28%)
Cash / Share
$1.39
Next Earnings Report
Mar 8, 2027
EPS est. -$0.35 · Revenue est. $30.3M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (5)

Dec 2026
Est. completion
NAParkinson's Disease
Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care
NCT04179695n=120
Apr 2027
Est. completion
P4Allergic Reactions
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
NCT06834165n=600
Jun 2027
Est. completion
P2Urticaria Chronic
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
NCT06927999n=42
Jun 2027
Est. completion
P4Chikungunya Virus Infection
Real-world Effectiveness, Safety & Immunogenicity of Chikungunya Vaccination: Ambispective Study in Reunion & French Guiana
NCT06928753n=1,505
Dec 2028
Est. completion
NAOral Cavity Cancer
Screening for Cancers in the Oral CAvity
NCT01958762n=100

Recent Press Releases

ARS Pharma to Report Third Quarter 2026 Financial Results
Oct 28, 2026 · GlobeNewsWire
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
Oct 5, 2026 · Business Wire
SPRY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Oct 5, 2026 · Business Wire
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
Oct 5, 2026 · PRNewsWire
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
Oct 5, 2026 · PRNewsWire
ARS PHARMACEUTICALS DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY
Oct 4, 2026 · Newsfile Corp
SPRY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Oct 4, 2026 · Newsfile Corp
SPRY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Oct 3, 2026 · Newsfile Corp
ARS PHARMACEUTICALS DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ARS Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY
Oct 3, 2026 · Newsfile Corp
ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
Oct 2, 2026 · PRNewsWire

SEC Filings (52)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Jul 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 17, 20268-KMaterial eventDocumentIndex
Jul 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 7, 20268-KMaterial eventDocumentIndex
Jun 25, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 15, 20268-KMaterial eventDocumentIndex
May 13, 20268-KMaterial eventDocumentIndex
Apr 29, 2026ARSAnnual report to holdersDocumentIndex
Apr 29, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 29, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 27, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 31, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 24, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 9, 2026S-8Employee stock planDocumentIndex
Mar 9, 202610-KAnnual reportDocumentIndex
Mar 9, 20268-KMaterial eventDocumentIndex
Feb 13, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 21, 2026SC 13GPassive 5%+ stakeDocumentIndex
Nov 10, 202510-QQuarterly reportDocumentIndex
Nov 10, 20258-KMaterial eventDocumentIndex
Oct 1, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 29, 20258-KMaterial eventDocumentIndex
Aug 28, 20258-KMaterial eventDocumentIndex
Aug 13, 202510-QQuarterly reportDocumentIndex
Aug 13, 20258-KMaterial eventDocumentIndex
Aug 1, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Jul 22, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Jul 2, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 26, 20258-KMaterial eventDocumentIndex
May 14, 202510-QQuarterly reportDocumentIndex
May 14, 20258-KMaterial eventDocumentIndex
May 2, 20258-KMaterial eventDocumentIndex
Apr 29, 2025ARSAnnual report to holdersDocumentIndex
Apr 29, 2025DEFA14AProxy / shareholder voteDocumentIndex